 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
San Francisco General Hospital
Table of Contents
Decmber 1997 EDITORIAL
A Good Year ...... and the promise of a better one to follow, for people living with HIV infectionPAUL A. VOLBERDING, M.D., EDITOR-IN-CHIEF
OPTIMAL MEDICAL MANAGEMENT Protease Inhibitor Resistance and Salvage TherapyWhat to do when a patient's initial antiretroviral regimen begins to failSTEVEN G. DEEKS, M.D.
PULL OUT AND SAVE Optimal Antiretroviral Therapy for HIV InfectionUpdated recommendations of the International AIDS Society - U.S.A.PAUL A. VOLBERDING, M.D.
NEWSLINE Newsline ... Newsline ... Newsline ...Cidofovir gel heals herpes lesions that do not respond to acyclovir ... More on how HIV enters cells ... New formulation of saquinavir, Fortovase®, has eight to nine times the bioavailability of Invirase® ... First test for HIV resistance to nucleoside analogs is available ... Gammaglobulin prevents infections in patients with low CD4 counts ... HIV found in lymph tissue of patients with "undetectable" viral levels ... The immune system vs. HIV: Tipping the balance in favor of viral control ... Drug-drug interactions -- an update: Use caution when mixing protease inhibitors and anticonvulsants ... Delavirdine and fluconazole can be taken together without adjusting doses ...THERAPEUTIC ADVANCES The Next Generation of Antiretroviral Agents -- An UpdateThe news gets better and better, as newer and more effective drugs are made available to treat patients with HIV infectionHAROLD A. KESSLER, M.D.
INDEX Index to Volume 3, Numbers 1-6An alphabetical listing of article titles and subjects covered in the third year of publication
Back to the December 1997 HIV Newsline contents page.
This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline. |
E-Mail
Printer Friendly
Glossary
Share
